Is Nike Stock a Buy in 2026? A Working Investor's Take

Is Nike stock a buy in 2026? At $46 a share — down from $179 at its 2021 peak — is Nike stock a buy is one of the most-asked questions among retail investors right now. The brand is iconic. The chart is ugly. A new CEO is mid-reset. The math will tell you exactly what kind of trade this actually is, if you let it.

This piece runs the same five-question framework value investors use on every position — applied directly to Nike, with every number pulled from the FY2025 10-K filed in July 2025 and current market data. By the end you will have a defensible answer to is Nike stock a buy at today's $46. You will also know exactly what assumption you would have to be right about to make the trade work. The question "is Nike stock a buy in 2026" is not the same as "do I like Nike" — the math tells you which.

## The Nike snapshot — the numbers that decide whether Nike stock is a buy

Nike's fiscal year 2025 ended May 31, 2025, and the 10-K was filed with the SEC on July 17, 2025.¹ The headline numbers:

Line item (NKE FY2025)	Value
Revenue	$46.31B
Net income	$3.22B
Cash from operating activities	$3.70B
Capital expenditures	$0.43B
Free cash flow	$3.27B
Stockholders' equity	$13.21B
Long-term debt	$7.96B
Common shares outstanding	1.48B
Share price at time of writing	$46.23
Implied market cap	~$68.4B

For context: FY2024 net income was roughly $5.7B; FY2025's $3.22B is a meaningful step down. Revenue contracted from FY2024's $51.4B peak. Margins compressed. The story is a brand that overshot on direct-to-consumer, lost shelf space at major retailers, and is now executing a wholesale-channel rebuild under a CEO who is twelve months into the job. The financials reflect a transition, not a collapse.

Question 1 — Is Nike a business you understand? (Step 1 of "is Nike stock a buy")

Nike designs and sells athletic footwear, apparel, and accessories under the Nike, Jordan, and Converse brands. It outsources manufacturing to a global contract network and earns its margin from brand pricing power plus a distribution model that mixes wholesale (DICK'S, Foot Locker, major retailers) with company-operated DTC channels. Two sentences. Pass.

Question 2 — Are Nike's numbers healthy on their own?

Five signatures, each with a concrete threshold:

Revenue 5-year CAGR. FY2020 revenue was $37.4B; FY2025 is $46.31B. CAGR ≈ 4.4%. Above the 3% threshold for a mature business. But materially below the company's longer-term trend, and the most recent year showed contraction. Marginal pass.

Operating margin trajectory. Gross margin contracted roughly 4 percentage points YoY (from ~46% to ~42%). Operating margin compressed similarly. The trajectory is unambiguously negative right now. Fail.

Return on invested capital. NOPAT ≈ $3.22B × 1.1 (tax-adjusted) ≈ $3.5B; invested capital is equity + LT debt ≈ $13.21B + $7.96B ≈ $21.2B. ROIC ≈ 16.5%. Above the 15% moat-grade threshold, but down from ~25-30% in better years. Marginal pass.

Free cash flow yield. $3.27B ÷ $68.4B = 4.78%. Compared to the 10-year Treasury at ~4.5%, Nike's FCF yield is barely above the risk-free rate. The "quality at a fair price" threshold (Treasury + 2 percentage points) wants 6.5% or better. Fail.

Net debt / EBITDA. LT debt $7.96B against FY2025 EBITDA (depressed) of roughly $4B → ~2.0x. Within the 3x ceiling. Pass.

Score: 3 marginal passes, 2 fails. The financial signatures say "weakened but not broken". A real buy would have 4 of 5 clear passes; on Question 2 alone, is Nike stock a buy is not a yes today.

Question 3 — Does Nike still have a moat?

Nike's moat is brand (an intangible-asset moat) plus partial network/scale effects in athlete sponsorship and global distribution. The financial signature of the moat — ROIC — has visibly weakened from ~28% historical to ~16% in FY2025. The moat is intact in narrative. It is not earning its premium in the numbers right now. The recovery thesis turns entirely on whether the brand still commands enough loyalty to fix the distribution mistake and restore margins. Verdict: moat exists, but narrower than three years ago.

Question 4 — Is the price below intrinsic value?

Owner earnings: $3.22B NI + ~$0.80B D&A − ~$0.35B maintenance capex ≈ $3.67B, or $2.48 per share. Apply Gordon growth at r = 10%, g = 3% (modest, reflecting transition uncertainty):

IV per share = 2.48 × 1.03 / 0.07 ≈ $36.49

At $46.23, Nike trades roughly 27% above this conservative IV. The market is pricing in some recovery already.

The kinder reading: if FY2025 is the trough and owner earnings normalise back toward FY2023's ~$5B over three years, the implied IV at the same r and g jumps to roughly $50 per share — putting price and value at parity. To get a meaningful margin of safety from today's $46, you need to believe earnings can normalise and keep growing modestly past prior levels.

Sensitivity table for Nike's IV per share (varying assumed owner earnings × discount rate; g = 3% throughout):

	Current trough OE	Halfway recovery	Full recovery to FY23
r = 8%	$51	$76	$107
r = 10%	$36	$54	$76

Nike at $46.23 sits inside the recovery scenarios but above the trough valuation. The trade exists; the price already prices in roughly half the recovery.

Question 5 — What would change your mind?

The recovery thesis can be stated as two specific tests you can verify in future filings.

1. Comparable-store sales growth in the US turns positive within 18 months. Nike's DTC contraction has been the leading indicator. Stabilisation reverses it.
2. Operating margin recovers above 12% within 36 months. FY2025 is at ~7-8%; historical is ~15-17%. Halfway back to history reopens the IV math.

If either fails, the thesis breaks and the position should be exited even at a loss. Writing these down before the trade is the difference between a value investment and a hope. Without those two written tests, the question is Nike stock a buy has no honest answer.

The bull case for Nike at $46

The bull case is the textbook value-investing recovery setup. A genuine high-quality brand (durable moat) has stumbled on execution (DTC overreach, China weakness, wholesale partner rebuild). New management is twelve months into a credible reset. Margins are at cyclical lows, not structural lows. The brand still commands shelf space, athlete sponsorship, and consumer mindshare. A return to even FY2022 margins (~13%) on FY2025-level revenue produces owner earnings well above $5B — implying IV in the $70-90 range against today's $46.

The bull does not require Nike to be the dominant athletic brand of 2030. It requires only that the current trough be a trough.

The bear case for Nike at $46

The bear case is that competitive position is structurally worse than the bull thinks. Hoka, On Running, New Balance, and Adidas have all been taking material share. The DTC mistake gave competitors a window that may not close. Margin compression is harder to reverse than analysts assume because the brand premium has actually narrowed. Greater China — historically Nike's highest-margin region — has structural problems beyond cyclical ones. The chart is ugly because the underlying business has changed, not because the market is wrong.

The bear does not require Nike to be terrible. It requires only that the FY2025 trough be the new normal rather than a low point.

So is Nike stock a buy?

Honestly: it depends on what you believe about the recovery. The numbers do not say "buy". They do not say "sell" either. At $46.23, the math says the market has priced in roughly half a recovery — meaningfully above conservative trough IV ($36), meaningfully below full recovery IV ($76 in the r = 10% / full normalisation scenario).

A defensible read on whether Nike stock is a buy today:

• If you have high conviction in the recovery thesis (CEO execution, brand durability, wholesale channel rebuild succeeding) — Nike at $46 is a value entry on a quality brand, with downside cushioned by the cash-rich balance sheet and remaining ROIC.
• If you have low conviction in the recovery — Nike at $46 is paying for upside that may not arrive, and the trough IV says wait. There is no urgency.
• If you have no view — the right answer is pass. Do not buy something where you cannot specify what would change your mind.

The five-question framework's job is to surface the assumption you would need to be right about. The assumption that decides whether Nike stock is a buy at $46 is the recovery itself. Decide whether you have an edge on that specific question. If yes, position-size for the named risk in Question 5. If no, move on.

## Frameworks behind this read

The five questions above are the same framework we apply on every "is X stock a buy" piece, including this one on whether Nike stock is a buy. Each step has a more rigorous version in the rest of the Hub. The margin of safety formula covers Step 7 (price vs IV). The owner earnings formula refines the cash-flow input. The economic moat guide explains why Nike's brand moat has narrowed. The full 7-step research workflow is what we apply to any new ticker. For the simpler entry point, the 5-question good-buy checklist is exactly what this piece runs.

For more long-form essays on value-investing methodology, see the rest of the Hub.